Expression of the COVID‐19 receptor ACE2 in the human conjunctiva

SARS‐CoV‐2 is assumed to use angiotensin‐converting enzyme 2 (ACE2) and other auxiliary proteins for cell entry. Recent studies have described conjunctival congestion in 0.8% of patients with laboratory‐confirmed severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), and there has been specul...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Med Virol
Päätekijät: Lange, Clemens, Wolf, Julian, Auw‐Haedrich, Claudia, Schlecht, Anja, Boneva, Stefaniya, Lapp, Thabo, Horres, Ralf, Agostini, Hansjürgen, Martin, Gottfried, Reinhard, Thomas, Schlunck, Günther
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7267303/
https://ncbi.nlm.nih.gov/pubmed/32374427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.25981
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia